WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009093972) ENANTIOMERICALLY PURE (-) 2-[1-(7-METHYL-2-(MORPHOLIN-4-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDIN-9-YL)ETHYLAMINO]BENZOIC ACID, ITS USE IN MEDICAL THERAPY, AND A PHARMACEUTICAL COMPOSITION COMPRISING IT - 026
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/093972    International Application No.:    PCT/SE2009/050065
Publication Date: 30.07.2009 International Filing Date: 22.01.2009
IPC:
C07D 471/04 (2006.01), A61K 31/519 (2006.01), A61K 31/5377 (2006.01), A61P 11/00 (2006.01), A61P 35/00 (2006.01), A61P 7/02 (2006.01), A61P 9/10 (2006.01)
Applicants: ASTRAZENECA AB [SE/SE]; S-151 85 Södertälje (SE) (For All Designated States Except US).
FJELLSTRÖM, Ola [SE/SE]; (SE) (For US Only).
GUSTAFSSON, David [SE/SE]; (SE) (For US Only).
JACKSON, Shaun [AU/AU]; (AU) (For US Only).
LINDBERG, Jan Å [SE/SE]; (SE) (For US Only)
Inventors: FJELLSTRÖM, Ola; (SE).
GUSTAFSSON, David; (SE).
JACKSON, Shaun; (AU).
LINDBERG, Jan Å; (SE)
Agent: ASTRAZENECA AB; AstraZeneca Intellectual Property S-151 85 Södertälje (SE)
Priority Data:
61/023,498 25.01.2008 US
Title (EN) ENANTIOMERICALLY PURE (-) 2-[1-(7-METHYL-2-(MORPHOLIN-4-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDIN-9-YL)ETHYLAMINO]BENZOIC ACID, ITS USE IN MEDICAL THERAPY, AND A PHARMACEUTICAL COMPOSITION COMPRISING IT - 026
(FR) ACIDE (-)2-[1-(7-MÉTHYL-2-(MORPHOLIN-4-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDIN-9-YL)ÉTHYLAMINO]BENZOÏQUE ÉNANTIOMÉRIQUEMENT PUR, SON UTILISATION EN THÉRAPIE MÉDICALE, ET COMPOSITION PHARMACEUTIQUE LE CONTENANT
Abstract: front page image
(EN)The present invention relates to enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-9- yl)ethylamino]benzoic acid or pharmaceutically acceptable salts thereof, it being in a solid state, its use in medical therapy, pharmaceutical composition comprising it, its use in the preparation of a medicament for use in a method for preventing or treating diseases, and its use in method for preventing or treating disease. The present invention relates to a selective inhibitor of phosphoinositide (PI) 3-kinase β and use of the selective inhibitor in e.g. anti-thrombotic therapy.
(FR)La présente invention concerne concerne l'acide (-)2-[l-(7-méthyl-2-(morpholin-4-yl)-4-oxo-4H-pyrido[l,2-α]pyrimidin-9-yl)éthylamino]benzoïque énantiomériquement pur ou ses sels pharmaceutiquement acceptables, dans un état solide, son utilisation en thérapie médicale, une composition pharmaceutique le contenant, son utilisation pour la préparation d'un médicament destiné à être utilisé dans une méthode de prévention ou de traitement de maladies, et son utilisation dans une méthode de prévention ou de traitement d'une maladie. La présente invention concerne un inhibiteur sélectif de la phosphoinositide (PI) 3-kinase β et son utilisation, notamment dans un traitement anti-thrombotique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)